Toceranib (as Phosphate) Chew Treat
Toceranib (as Phosphate) is an FDA-approved preparation containing toceranib (as phosphate), for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
Toceranib phosphate is an orally active receptor tyrosine kinase inhibitor utilized for managing specific canine cancers. It is a prescription medication requiring professional oversight by a licensed veterinarian. It is frequently considered in the context of oncology for patients presented with grade II or III mast cell tumors.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it is used in the context of managing the biological activity of receptor tyrosine kinases, providing an approach for managing tumor growth and angiogenesis. Commonly observed effects include localized digestive changes such as diarrhea or a decrease in appetite. Because it may influence multiple pathways, your veterinarian will monitor for observational signs of toxicity through regular blood and urine tests. Owners should follow all safety precautions, including wearing gloves when handling the medication.
Yes. Toceranib phosphate is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all professional standards.
Yes. Mixlab specializes in compounding toceranib phosphate into customized strengths and flavored oral formats to suit the specific needs of your pet as directed by your veterinarian.
Veterinarians discuss toceranib phosphate because it targets the specific signaling pathways that these tumors use to grow. This offers an approach to managing tumor progression.
You should monitor for observational signs like persistent vomiting, weight loss or weakness. If you notice these shifts, contact your veterinarian immediately for a clinical review.
Because toceranib can influence renal function, your veterinarian will perform regular urinalysis and blood work. This monitoring ensures the management approach remains suitable.
